Listed

Omega Healthcare Investors Inc

OHINYSECIK 888491Real estateFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$14.0mRevenue, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Jul 30, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$14.0mRevenue, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure−95.0% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating margin2365.9%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $330.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Revenue: $14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure+2266.3 pts on a year earlier
  • Net margin2594.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $362.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Revenue: $14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure+2545.6 pts on a year earlier
  • Diluted EPS$1.19Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure+158.7% on a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$14.0mOperating margin 2365.9%
Diluted EPS$1.19, Q2 FY2026
Omega Healthcare Investors Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m276Revenue, Q3 FY2024, three months to 2024-09-30$276.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure279Revenue, Q4 FY2024, three months to 2024-12-31$279.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure277Revenue, Q1 FY2025, three months to 2025-03-31$276.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure283Revenue, Q2 FY2025, three months to 2025-06-30$282.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure312Revenue, Q3 FY2025, three months to 2025-09-30$311.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure319Revenue, Q4 FY2025, three months to 2025-12-31$319.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure6.7Revenue, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure14.0Revenue, Q2 FY2026, three months to 2026-06-30$14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)99.6%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $281.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Revenue: $282.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figurenot reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)2365.9%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: $330.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Revenue: $14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Net margin%40.5%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $111.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Revenue: $276.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure40.6%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $113.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $279.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure39.4%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $109.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Revenue: $276.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure48.4%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $136.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Revenue: $282.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure57.7%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $179.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Revenue: $311.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figure51.6%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $164.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $319.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure2269.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $151.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Revenue: $6.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure2594.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: $362.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Revenue: $14.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Diluted EPS$ per share0.42Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figurenot reported (Diluted EPS not reported)0.33Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure0.46Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure0.59Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-31, accession 0000888491-25-000040.Report this figurenot reported (Diluted EPS not reported)0.47Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0000888491-26-000018.Report this figure1.19Diluted EPS, Q2 FY2026, three months to 2026-06-30$1.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0000888491-26-000024.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$1.19bnNet margin 49.6%
Diluted EPS$1.94, FY2025
Omega Healthcare Investors Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,063Revenue, FY2021, twelve months to 2021-12-31$1.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-12, accession 0000888491-24-000007.Report this figure878Revenue, FY2022, twelve months to 2022-12-31$878.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure950Revenue, FY2023, twelve months to 2023-12-31$949.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure1,051Revenue, FY2024, twelve months to 2024-12-31$1.05bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure1,190Revenue, FY2025, twelve months to 2025-12-31$1.19bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%40.3%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $428.3m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2024-02-12, accession 0000888491-24-000007.Revenue: $1.06bn. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-12, accession 0000888491-24-000007.Report this figure50.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $438.8m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2025-02-13, accession 0000888491-25-000006.Revenue: $878.2m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure25.5%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $242.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008.Revenue: $949.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure38.6%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $406.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008.Revenue: $1.05bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure49.6%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $590.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-09, accession 0000888491-26-000008.Revenue: $1.19bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure
Diluted EPS$ per share1.75Diluted EPS, FY2021, twelve months to 2021-12-31$1.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-12, accession 0000888491-24-000007.Report this figure1.80Diluted EPS, FY2022, twelve months to 2022-12-31$1.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-13, accession 0000888491-25-000006.Report this figure1.00Diluted EPS, FY2023, twelve months to 2023-12-31$1.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure1.55Diluted EPS, FY2024, twelve months to 2024-12-31$1.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure1.94Diluted EPS, FY2025, twelve months to 2025-12-31$1.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-09, accession 0000888491-26-000008.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Omega Healthcare Investors Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$1.84bn38,551,916Added+1,350,553
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$1.30bn27,229,625Added+106,508
STATE STREET CORP2026-06-30$692.7m14,527,955Reduced−45,358
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$640.7m13,436,631Added+202,510
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$435.9m9,141,024Added+212,917
Invesco Ltd.2026-06-30$280.8m5,889,795Reduced−33,242
Bank of New York Mellon Corp2026-06-30$275.2m5,772,439Added+1,478,627
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2026-06-30$229.7m4,818,440Added+201,768
DIMENSIONAL FUND ADVISORS LP2026-06-30$210.7m4,418,159Reduced−4,961
NORGES BANK2026-06-30$190.2m3,989,606New+3,989,606

Recent filings

All 1,554 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Omega Healthcare Investors Inc, recent filings
FiledFormWhat it isAccession number
2026-10-0506:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-113450
2026-10-0108:20 ET8-K5.02 Departure or appointment of officers or directors0001104659-26-112589
2026-07-3011:13 ET10-QQuarterly reportPeriod 2026-06-300000888491-26-000024
2026-07-2916:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000888491-26-000022
2026-06-0516:15 ET8-K5.07 Shareholder vote results; 8.01 Other events0001104659-26-070979
2026-05-2116:16 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-065158
2026-04-2911:02 ET10-QQuarterly reportPeriod 2026-03-310000888491-26-000018
2026-04-2816:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000888491-26-000016
2026-04-2108:31 ETDEF 14AProxy statementPeriod 2026-06-050001104659-26-045753
2026-02-0910:58 ET10-KAnnual reportPeriod 2025-12-310000888491-26-000008

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 9, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
888491
Tickers
OHI
Exchange
NYSE
SIC code
6798 Real Estate Investment Trusts
Sector
Real estate
Fiscal year ends
Dec 31
Incorporated in
MD
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:15 ET. Listed shows no prices and gives no investment advice.